About this trial
To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years
English as a primary language
Participants with a diagnosis of HNC undergoing active curative RT or having received curative RT within the past 5 years at MD Anderson
Ability to complete the survey(s) of their own volition
Disqualifiers
Age < 18 years
Non-English speaking participants
Participants who are receiving or have received RT in a non-HN site.
Participants in follow up and over 5 years from post-treatment
Trial population
Head and Neck Cancer (HNC) participants undergoing active radiation therapy.
Trial design
Cohort
Prospective
Treatments tested in this trial
MDASI-HN
Other interventionGiven by Questionnaire
EORTC QLQ-C30
Other interventionGiven by Questionnaire
EORTC HN35
Other interventionGiven by Questionnaire
Treatment groups
Trial outcomes
Primary outcomes
Safety and adverse events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.